Your browser doesn't support javascript.
loading
NPT1220-312, a TLR2/TLR9 Small Molecule Antagonist, Inhibits Pro-Inflammatory Signaling, Cytokine Release, and NLRP3 Inflammasome Activation.
Habas, Agata; Reddy Natala, Srinivasa; Bowden-Verhoek, Jon K; Stocking, Emily M; Price, Diana L; Wrasidlo, Wolfgang; Bonhaus, Douglas W; Gill, Martin B.
Affiliation
  • Habas A; Arrowhead Pharmaceuticals Inc., 11404 Sorrento Valley Road, San Diego, CA 92121, USA.
  • Reddy Natala S; Zentalis Pharmaceuticals, 10835, Road to the Cure Suite 205, San Diego, CA 92121, USA.
  • Bowden-Verhoek JK; Neuropore Therapies Inc., 11585 Sorrento Valley Rd. Suite 106, San Diego, CA 92121, USA.
  • Stocking EM; Neuropore Therapies Inc., 11585 Sorrento Valley Rd. Suite 106, San Diego, CA 92121, USA.
  • Price DL; Neuropore Therapies Inc., 11585 Sorrento Valley Rd. Suite 106, San Diego, CA 92121, USA.
  • Wrasidlo W; Neuropore Therapies Inc., 11585 Sorrento Valley Rd. Suite 106, San Diego, CA 92121, USA.
  • Bonhaus DW; Neuropore Therapies Inc., 11585 Sorrento Valley Rd. Suite 106, San Diego, CA 92121, USA.
  • Gill MB; Libra Therapeutics, 3210 Merryfield Row, San Diego, CA 92121, USA.
Int J Inflam ; 2022: 2337363, 2022.
Article in En | MEDLINE | ID: mdl-35265316

Full text: 1 Database: MEDLINE Language: En Journal: Int J Inflam Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Database: MEDLINE Language: En Journal: Int J Inflam Year: 2022 Type: Article Affiliation country: United States